To facilitate the achieving of the goal of" eliminating viral hepatitis as a major public health
threat by 2030" set by the World Health Organization, the Chinese Society of Hepatology …

Chronic hepatitis B (CHB) is a dynamic disease that is influenced by host and virological
factors. The management of CHB has become more complex with the increasing use of long …

Our understanding of the natural history of hepatitis B virus (HBV) infection and the potential
for therapy of the resultant disease has improved. Several new and effective antiviral agents …

Based on the progression of clinical and basic research in hepatitis B virus (HBV), we
updated the previous HBV guidelines from 2015. The guidelines included the prevention …

Hepatitis B virus (HBV) infection remains a global public health problem with changing
epidemiology due to several factors including vaccination policies and migration. This …

Chronic hepatitis B (CHB) is a major cause of chronic liver diseases in Korea and remains a
threat to public health due to its high morbidity and disease-related mortality. Since the latest …

An estimated 350 million persons worldwide and 1.25 million in the United States are
infected with hepatitis B virus (HBV). Hepatitis B carriers are at risk for development of …

More than 2 billion people have been exposed to the hepatitis B virus (HBV) of whom an
estimated 257 million people have chronic infection. 1 Chronic HBV infection occurs globally …

Currently, despite the use of a preventive vaccine for several decades as well as the use of
effective and well-tolerated viral suppressive medications since 1998, approximately 250 …

These are the first World Health Organization (WHO) guidelines for the prevention care and
treatment of persons living with CHB infection and complement similar recent published …